Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
Vaccine|October 15, 2025
TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targetsEmma Falling Iversen, Anna H F Rahimic, Giacomo S Frattari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 8, 2011
Tenofovir selectively regulates production of inflammatory cytokines and shifts the IL-12/IL-10 balance in human primary cellsJesper Melchjorsen, Michael W Risør, Ole S Søgaard, et al.
Virology|May 25, 2025
Vectored long-term co-delivery of antibodies for SARS-CoV-2, RSV and Influenza prophylaxisStine Sofie Frank Lende, Frederik Holm Rothemejer, Malthe Andreas, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2015
Histone deacetylase inhibitor romidepsin inhibits de novo HIV-1 infectionsKasper L Jønsson, Martin Tolstrup, Johan Vad-Nielsen, et al.
Plos Pathogens|August 26, 2016
Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV RemissionMykola Pinkevych, Deborah Cromer, Martin Tolstrup, et al.
ACS Macro Letters|June 2, 2022
Synthetic Polymer with a Structure-Driven Hepatic Deposition and Curative Pharmacological Activity in Hepatic CellsCamilla Frich Riber, Anna Halling Folkmar Andersen, Lærke Anegaard Rolskov, et al.
Plos Pathogens|July 3, 2015
HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV RemissionMykola Pinkevych, Deborah Cromer, Martin Tolstrup, et al.
Mediators of Inflammation|December 24, 2015
Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 PatientsAne Bjerg Christensen, Anders Dige, Johan Vad-Nielsen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 16, 2018
Non-covalent hitchhiking on endogenous carriers as a protraction mechanism for antiviral macromolecular prodrugsCamilla Kaas Frich, Franziska Krüger, Raoul Walther, et al.
Frontiers in Cellular and Infection Microbiology|July 22, 2022
CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist ImmunotherapyStine Sofie Frank Lende, Marie Høst Pahus, Ida Monrad, et al.
Pageof 14